We are thrilled to announce that RIC3D has been admitted to Phase 2 of Innovit – Italian Innovation and Culture Hub, scheduled from June 3rd to 14th, 2024, at the Italian Innovation Center in San Francisco, California.


The Italian Innovation and Culture Hub in San Francisco, known as INNOVIT, is a strategic hub for the internationalization and integrated promotion of the Italian system in the United States.

Promoted by the Directorate General for Country System of the Ministry of Foreign Affairs and International Cooperation, in collaboration with the Embassy of Italy in Washington and the Consulate General in San Francisco, INNOVIT is implemented by Fondazione Giacomo Brodolini and Entopan Innovation, with the involvement of ICE – Italian Trade Agency and the Italian Cultural Institute in San Francisco.


RIC3D’s Innovative project: Real Organ Generation (ROG)

As an innovative benefit startup specializing in the development of software for medical diagnosis and surgical training, RIC3D will participate in the “Startup Acceleration (Life Sciences & Digital Health)” program with its project ROG (Real Organ Generation).

The highly interactive and responsive software developed by the RIC3D team allows up to four users to operate in a Virtual Room as real surgeons: users can perform virtual surgical simulations using ultra-detailed 3D models of real human organs obtained from patients’ computed tomography (CT) scans, with a particular focus on the heart.

Participation and goals

After successfully completing Phase 1 of the Innovit program – which involved 40 startups and 25 SMEs in online activities such as orientation, needs analysis, mentorship, and tutoring – RIC3D is now ready to tackle Phase 2. This phase includes an intensive acceleration program in Silicon Valley, featuring workshops, mentoring sessions, networking with startups, major tech companies, venture capitalists, and industry experts, along with visits to major tech company headquarters and participation in high-profile events such as Demo Day.

RIC3D’s CEO, Clara Bernasco, alongside CSO Riccardo Roggeri, will travel to the United States to participate in this program. The goal is to accelerate RIC3D’s international growth, guide business strategies through interaction with top mentors, and establish relationships with investors and strategic partners, thereby enhancing RIC3D’s competitiveness and innovation in the Med-Tech field.